These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33604389)

  • 1. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
    Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
    BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
    Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
    PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
    Ko KS; Lee M; Koh JJ; Kim SW
    Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
    Osada Y; Fujiyama T; Kamimura N; Kaji T; Nakae S; Sudo K; Ishiwata K; Kanazawa T
    Exp Parasitol; 2017 Jun; 177():1-12. PubMed ID: 28363777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
    Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
    Müller A; Schott-Ohly P; Dohle C; Gleichmann H
    Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
    Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
    BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
    Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
    Front Immunol; 2018; 9():2646. PubMed ID: 30498495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Delivery of Proinsulin and IL-10 via
    Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
    Front Immunol; 2020; 11():1103. PubMed ID: 32582188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
    Seifarth C; Pop S; Liu B; Wong CP; Tisch R
    J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus.
    Zhang L; Chen Y; Li C; Lin X; Cheng X; Li T
    PLoS One; 2014; 9(3):e92616. PubMed ID: 24663217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.
    Anastasi E; Campese AF; Bellavia D; Bulotta A; Balestri A; Pascucci M; Checquolo S; Gradini R; Lendahl U; Frati L; Gulino A; Di Mario U; Screpanti I
    J Immunol; 2003 Nov; 171(9):4504-11. PubMed ID: 14568923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
    J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
    Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
    Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.